The Effects of Non-surgical Periodontal Therapy in Patients Indicated for Bariatric Surgery
1 other identifier
interventional
70
1 country
1
Brief Summary
By World Health Organization (WHO) definition overweight (body mass index (BMI) \>24.9) and obesity (BMI \>29.9) are defined as abnormal or excessive fat accumulation with many possible impacts on individual's health. Association between obesity and associated metabolic syndrome (obesity, hypertension, diabetes mellitus type 2 and dyslipidemia) and oral health has become clear from several studies that proved increased odds of obese patients for developing of caries-related pathologies and periodontal disease. Periodontal disease, a major cause of tooth loss in adults, is an inflammatory disease of periodontal tissue that is initiated by dental plaque bacteria and is modulated by the inflammatory-immune host response factors. Relation between periodontal disease and obesity is bi-directional, through sharing of several proposed local and systemic pathogenesis mechanisms. For treatment of obesity, bariatric surgery (BS) procedures are methods of choice, when other less invasive options fail. They are safe, cost-effective, improve overall health and increase life expectancy. There are several types of BS interventions and most commonly performed BS is laparoscopic sleeve gastrectomy and with second most often, Roux-en-Y gastric bypass. Studies on influence of BS on periodontal health showed diverse results, with some showing no effect, while others demonstrated an increase in the prevalence of periodontitis as well as a further deterioration of periodontal tissues after BS procedure. However, studies on the prevalence of gingivitis, a reversible plaque-induced inflammation of gingiva, and its progression to periodontitis in BS patients is lacking. Furthermore, dental and periodontal status are not routinely evaluated in patients before or after BS. To the best of our knowledge studies on the effect of periodontal therapy before BS are lacking.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2020
CompletedFirst Submitted
Initial submission to the registry
October 23, 2020
CompletedFirst Posted
Study publicly available on registry
December 4, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2021
CompletedDecember 17, 2021
December 1, 2021
1.5 years
October 23, 2020
December 6, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Percentage of Bleeding on Probing (BOP) Sites
Percentage of probing sites that bleed will be calcuated from fill mouth record
at 7 months after treatment
Secondary Outcomes (3)
Probing Pocket Depth (PPD) change
at 7 months post treatment
Clinical Attachment Level (CAL) change
at 7 months post treatment
C-reactive protein (CRP)
at 7 months post treatment
Other Outcomes (1)
Oral Health Impact Profile (OHIP) -14 questionnaire
at 7 months post treatment
Study Arms (4)
Full mouth debridement
EXPERIMENTALSupragingival plaque/calculus removal and scaling and root planing
Supragingival plaque/calculus removal
SHAM COMPARATORSupragingival plaque and calculus removal
Probiotic lozenges
EXPERIMENTALDaily usage of probiotic lozenges
Placebo lozenges
ACTIVE COMPARATORDaily usage of placebo lozenges
Interventions
Patients with periodontitis in the test group will be treated by conventional non-surgical root debridement and in the control group by low-intensive supragingival plaque removal with mechanical brush and professional tooth paste only.
Patients with gingivitis in the test group will be treated with supragingival debridement and with probiotic lozenges with strains of Lactobacillus brevis and Lactobacillus plantarum once a day for 3 months and in the control group by low-intensive supragingival plaque removal, as a placebo treatment, and placebo probiotics lozenges.
Eligibility Criteria
You may qualify if:
- ≥18 years patients undergoing BS (morbidly obese patients (obesity class III) and obese patients (class II and I) with obesity related comorbidities: diabetes mellites type II, Hypertension, hyperlipidaemia, obstructive sleep apnea, articular pain, polycystic ovary syndrome) from Department of Abdominal Surgery, University Medical Centre Ljubljana.
- ≥ 16 teeth present
- Diagnoses with periodontitis or gingivitis
- Singed consent
You may not qualify if:
- Antibiotic and periodontal therapy in previous 6 months
- The need of prophylactic antibiotic therapy
- Pregnant women, lactation
- Cancer and other serious chronic diseases (excluding metabolic syndrome) with known influence on periodontal health
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Medical Centre
Ljubljana, 1000, Slovenia
Related Publications (1)
Colak D, Cmok Kucic A, Pintar T, Gaspirc B, Gaspersic R. Periodontal and systemic health of morbidly obese patients eligible for bariatric surgery: a cross-sectional study. BMC Oral Health. 2022 May 13;22(1):174. doi: 10.1186/s12903-022-02207-0.
PMID: 35562737DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 23, 2020
First Posted
December 4, 2020
Study Start
June 1, 2020
Primary Completion
November 30, 2021
Study Completion
November 30, 2021
Last Updated
December 17, 2021
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share